In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
As of close of business last night, Ocular Therapeutix Inc’s stock clocked out at $7.64, down -6.03% from its previous closing price of $8.13. In other words, the price has decreased by -$6.03 from its previous closing price. On the day, 1.03 million shares were traded. OCUL stock price reached its highest trading level at $8.2 during the session, while it also had its lowest trading level at $7.63.
Ratios:
To gain a deeper understanding of OCUL’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.94 and its Current Ratio is at 13.01. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.21.
On June 20, 2024, TD Cowen Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $7 to $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 04 ’25 when Notman Donald sold 11,119 shares for $7.81 per share. The transaction valued at 86,839 led to the insider holds 193,444 shares of the business.
Notman Donald sold 6,301 shares of OCUL for $49,400 on Jan 31 ’25. The insider now owns 204,563 shares after completing the transaction at $7.84 per share. On Feb 04 ’25, another insider, DONALD D NOTMAN JR., who serves as the Officer of the company, bought 11,119 shares for $7.81 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OCUL now has a Market Capitalization of 1201137792 and an Enterprise Value of 1161941120. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.55 while its Price-to-Book (P/B) ratio in mrq is 3.40. Its current Enterprise Value per Revenue stands at 19.018 whereas that against EBITDA is -10.492.
Stock Price History:
The Beta on a monthly basis for OCUL is 1.32, which has changed by 0.43133807 over the last 52 weeks, in comparison to a change of 0.20587826 over the same period for the S&P500. Over the past 52 weeks, OCUL has reached a high of $11.77, while it has fallen to a 52-week low of $4.06. The 50-Day Moving Average of the stock is -11.21%, while the 200-Day Moving Average is calculated to be -5.60%.
Shares Statistics:
It appears that OCUL traded 908.43K shares on average per day over the past three months and 973640 shares per day over the past ten days. A total of 156.65M shares are outstanding, with a floating share count of 135.64M. Insiders hold about 13.72% of the company’s shares, while institutions hold 75.91% stake in the company. Shares short for OCUL as of 1730332800 were 12671361 with a Short Ratio of 12.28, compared to 1727654400 on 16194368. Therefore, it implies a Short% of Shares Outstanding of 12671361 and a Short% of Float of 8.1599995.
